SCHEMBL4346849

SCHEMBL4346849

Oc1c(Cl)cc(Cl)cc1NC(=S)Nc1ccccc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.68
NPC1 O15118 1/20 0.68
HTT P42858 1/20 0.68
RAB9A P51151 1/20 0.68
MAPT P10636 3/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
NPSR1 Q6W5P4 1/20 0.55
CYP3A4 P08684 1/20 0.53
TAS2R38 P59533 1/20 0.53
HSD17B10 Q99714 1/20 0.53
KMT2A Q03164 2/20 0.50
NCOA3 Q9Y6Q9 2/20 0.50
NOX1 Q9Y5S8 1/20 0.50
LMNA P02545 1/20 0.50
GAA P10253 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
ALOX12 P18054 1/20 0.50
PPARG P37231 1/20 0.50
NCOA1 Q15788 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4353440 0.89 ALDH1A1 (0.56) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL4346888 0.85 ALDH1A1 (0.54) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL4351892 0.82 ALDH1A1 (0.63) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL4354217 0.81 MAPT (0.53) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL4358279 0.81 MEN1 (0.63) NPC1HTTRAB9AMAPTSMN1; SMN2
SCHEMBL12846663 0.81 ALDH1A1 (0.47) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL25786764 0.81 ALDH1A1 (0.46) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL21858367 0.81 ALDH1A1 (1.00) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL31206339 0.81 ALDH1A1 (1.00) ALDH1A1NPC1HTTRAB9AMAPT
SCHEMBL4347312 0.81 ALDH1A1 (0.58) ALDH1A1NPC1HTTRAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
CN-1701061-A Novel compounds for inhibiting rotamase enzymes and uses thereof JERINI AG (DE) 2005-11-23 CN claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 ALDH1A1 2565/4885NPC1 815/4885HTT 3824/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 ALDH1A1 2767/4885NPC1 1189/4885HTT 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.